Cai Junxiu, Xu Hai, Xiao Rongzhou, Hu Liping, Xu Ping, Guo Xianbin, Xie Yu, Pan Min, Tang Jie, Gong Qingtao, Liu Yan, Su Rong, Deng Jiahua, Wang Li
Department of Neurology, Zigong Third People's Hospital, Zigong, China.
Department of Neurology, Ziyang People's Hospital, Ziyang, China.
Front Neurol. 2023 Jan 25;14:1023089. doi: 10.3389/fneur.2023.1023089. eCollection 2023.
Intracranial rescue stenting (RS) might be an option for acute ischemic stroke after the failure of mechanical thrombectomy (MT). However, the findings were not consistent in previous systematic reviews, and whether the conclusion was supported by sufficient statistical power is unknown.
To examine the effect of RS on acute ischemic stroke after the failure of MT with a systematic review, meta-analysis, and trial sequential analysis (TSA).
We searched Ovid Medline, Embase, and the Cochrane Central Register of Controlled Trials (CENTRAL) from inception to 15 June 2022, without any language restriction. Studies assessing the effect of RS for acute ischemia stroke after MT failure were included. Two reviewers independently screened the retrieved articles, extracted data, and evaluated the quality of the included studies through the New Ottawa Scale (NOS). The primary outcome was the recanalization rate after RS. Secondary outcomes included modified Rankin Scale (mRS) at 3 months after stroke, symptomatic intracranial hemorrhage (sICH), and mortality rate. We synthesized the data through a random-effects model and performed a TSA analysis.
We included 15 studies (containing 1,595 participants) after screening 3,934 records. The pooled recanalization rate for rescue stenting was 82% (95% CI 77-87%). Compared with non-stenting, rescue stenting was associated with a higher proportion of patients with 0-2 mRS score (OR 3.96, 95% CI 2.69-5.84, < 0.001) and a lower 90-day mortality rate (OR 0.46, 95% CI 0.32-0.65, < 0.001), and stenting did not increase sICH rate (OR 0.63, 95% CI 0.39-1.04, = 0.075). The TSA analysis showed that the meta-analysis of the mRS score had a sufficient sample size and statistical power.
Our study showed that rescue stenting was effective and safe for patients with acute ischemia stroke who also had a failed MT, and this result was confirmed in a TSA analysis.
对于机械取栓(MT)失败后的急性缺血性卒中患者,颅内挽救性支架置入术(RS)可能是一种选择。然而,在既往的系统评价中,研究结果并不一致,且其结论是否有足够的统计学效力支持尚不清楚。
通过系统评价、荟萃分析和试验序贯分析(TSA)来研究RS对MT失败后的急性缺血性卒中的影响。
我们检索了从数据库建库至2022年6月15日的Ovid Medline、Embase和Cochrane对照试验中心注册库(CENTRAL),无语言限制。纳入评估RS对MT失败后的急性缺血性卒中疗效的研究。两名研究者独立筛选检索到的文章,提取数据,并通过新渥太华量表(NOS)评估纳入研究的质量。主要结局是RS后的再通率。次要结局包括卒中后3个月的改良Rankin量表(mRS)评分、症状性颅内出血(sICH)和死亡率。我们通过随机效应模型进行数据合并,并进行TSA分析。
在筛选了3934条记录后,我们纳入了15项研究(共1595名参与者)。挽救性支架置入术的合并再通率为82%(95%CI 77%-87%)。与未行支架置入术相比,挽救性支架置入术使mRS评分为0-2分的患者比例更高(OR=3.96,95%CI 2.69-5.84,P<0.001),90天死亡率更低(OR=0.46,95%CI 0.32-0.65,P<0.001),且支架置入术并未增加sICH发生率(OR=0.63,95%CI 0.39-1.04,P=0.075)。TSA分析显示,mRS评分的荟萃分析有足够的样本量和统计学效力。
我们的研究表明,对于MT失败的急性缺血性卒中患者,挽救性支架置入术是有效且安全的,且这一结果在TSA分析中得到了证实。